EXANE

a leader in European equities

As of 13 July 2021, BNP Paribas received the necessary approvals and acquired 100% of Exane, raising its stake from the 50% previously held during a successful 17-year partnership. This transaction will further strengthen and widen the range of cash equities (execution and research) and derivatives services BNP Paribas can offer to institutional investors and corporates globally.

BNP Paribas Corporate and Institutional Banking (CIB) is a globally recognised leader offering tailored financial solutions for corporate and institutional clients, including capital markets issuance, securities services, financing, treasury, advisory solutions, risk management and hedging. By matching the financing needs of companies with the investment opportunities sought by institutional investors, BNP Paribas CIB's financial solutions create value while contributing to the financing of the economy. Click here for more information about BNP Paribas CIB.

Note: BNP Paribas and Exane are working closely towards a seamless and smooth transition, which includes the sharing of certain client information, in line with each entity's regulatory requirements.

Cash equities

Under the brand name BNP Paribas Exane, Cash Equities provides institutional investors with a full range of Execution, Research, Sales and Corporate Access services.

News
27 APRIL 2023 - BNP PARIBAS EXANE LEADS TRADE'S 2023 ALGO TRADING SURVEY FOR LONG-ONLY
30 MARCH 2023 - An Investor Relations presentation day dedicated to HEC Paris students
10 NOVEMBER 2022 - BNP PARIBAS EXANE SURVEY: 10 TOP ESG CHALLENGES FOR INVESTOR CORPORATE RELATIONS
3 November 2022 - BNP Paribas Exane awarded Best Large-Cap Provider and Best User Experience by The Trade
7 SEPTEMBER 2022 – INSTITUTIONAL INVESTOR SURVEY 2022: BNP PARIBAS EXANE RANKS #1 FOR INDUSTRY RESEARCH IN EUROPE FOR THE 6TH CONSECUTIVE YEAR
17 June 2022 - 24th CEO Conference of BNP Paribas Exane
12 April 2022 - BNP Paribas Exane ranks #1 in The Trade’s Algorithmic Trading Survey
28 January 2022 - BNP Paribas Exane and BNP Paribas were part of the IR 22 Virtual Week event
5 November 2021 - Exane BNP Paribas wins two awards at The Trade's Leader in Trading 2021 ceremony
14 Octobre - Exane BNP Paribas strengthens the Dach Research team in Frankfurt
12 October 2021 - Kepler Cheuvreux announces the acquisition of Ellipsis AM
16 September 2021 - Institutional Investor 2021 Survey: Exane BNP Paribas ranked no.1 for 5 years in a row
14 September 2021 - Exane Pleiade Performance has been awarded in the absolute return category by Gestion de Fortune
13 July 2021 - BNP Paribas receives approvals and completes the acquisition of Exane
STRATEGIC INFORMATION
>
BNP Paribas is looking to acquire up to 100% of Exane (March 2021)
>
BNP Paribas receives approvals and completes the acquisition of Exane (July 2021)
ANNOUNCEMENT
Exane Convertibles Indices Termination
>
Notice of Index Termination – 30 September 2022
ANNOUNCEMENT
ACQUISITION OF ELLIPSIS AM BY
KEPLER CHEUVREUX
>
Press release - 31 January 2022
>
Press release - 12 October 2021

Covid-19: Our commitment through the crisis

Key figures

600

employees

397.1

million of euros of NBI in 2021

131.9

million of euros in net profit in 2021


6, rue Ménars 75002 Paris – France
Tel:+33 (0)1 44 95 40 00

REGULATORY

CAREERS

News

OPERATIONS

complaints